Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$59.06 - $75.72 $20,671 - $26,502
-350 Reduced 9.98%
3,157 $233,000
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $7,020 - $10,645
112 Added 3.3%
3,507 $329,000
Q1 2023

May 04, 2023

BUY
$47.19 - $70.77 $160,210 - $240,264
3,395 New
3,395 $230,000
Q2 2021

Aug 06, 2021

SELL
$93.66 - $139.27 $16,203 - $24,093
-173 Reduced 7.14%
2,250 $280,000
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $8,509 - $11,315
-73 Reduced 2.92%
2,423 $319,000
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $13,845 - $19,754
-139 Reduced 5.28%
2,496 $331,000
Q4 2019

Feb 11, 2020

SELL
$77.66 - $99.74 $31,064 - $39,896
-400 Reduced 13.18%
2,635 $244,000
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $2.49 Million - $3.37 Million
-27,500 Reduced 90.06%
3,035 $274,000
Q2 2019

Aug 12, 2019

SELL
$89.51 - $118.04 $5.04 Million - $6.65 Million
-56,359 Reduced 64.86%
30,535 $3.6 Million
Q1 2019

May 13, 2019

BUY
$61.98 - $96.5 $27,023 - $42,074
436 Added 0.5%
86,894 $7.53 Million
Q4 2018

Feb 12, 2019

SELL
$56.04 - $82.66 $1.37 Million - $2.02 Million
-24,463 Reduced 22.05%
86,458 $5.46 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $2.68 Million - $4.48 Million
55,552 Added 100.33%
110,921 $8.75 Million
Q2 2018

Aug 09, 2018

SELL
$37.84 - $69.96 $1.91 Million - $3.54 Million
-50,585 Reduced 47.74%
55,369 $3.31 Million
Q4 2017

Jan 31, 2018

BUY
$46.49 - $60.51 $34,030 - $44,293
732 Added 0.7%
105,954 $5.57 Million
Q3 2017

Oct 18, 2017

BUY
$37.05 - $47.12 $3.9 Million - $4.96 Million
105,222
105,222 $4.96 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.